Open access
121
Views
4
CrossRef citations to date
0
Altmetric
Original Research
An Optimized Integrin α6-Targeted Magnetic Resonance Probe for Molecular Imaging of Hepatocellular Carcinoma in Mice
Bing-Quan Lin1 Department of Medical Imaging Center, Nanfang Hospital, Southern Medical University, Guangzhou City, Guangdong Province, 510515, People’s Republic of China
, Wen-Biao Zhang2 State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, 510060, People’s Republic of China;3 Department of Medical Imaging, Sun Yat-sen University Cancer Center, Guangzhou, 510060, People’s Republic of China
, Jing Zhao3 Department of Medical Imaging, Sun Yat-sen University Cancer Center, Guangzhou, 510060, People’s Republic of China
, Xu-Hui Zhou4 Department of Radiology, The Eighth Affiliated Hospital, Sun Yat-sen University, Shenzhen, 518033, People’s Republic of China
, Yong-Jiang Li2 State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, 510060, People’s Republic of China
, Jun Deng5 Department of Biological Products, Guangdong Institute for Drug Control, Guangzhou, 510663, People’s Republic of China
, Qin Zhao2 State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, 510060, People’s Republic of China;3 Department of Medical Imaging, Sun Yat-sen University Cancer Center, Guangzhou, 510060, People’s Republic of China
, Gui Fu2 State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, 510060, People’s Republic of China;3 Department of Medical Imaging, Sun Yat-sen University Cancer Center, Guangzhou, 510060, People’s Republic of China
, Chuan-Miao Xie3 Department of Medical Imaging, Sun Yat-sen University Cancer Center, Guangzhou, 510060, People’s Republic of China
, Yi-Kai Xu1 Department of Medical Imaging Center, Nanfang Hospital, Southern Medical University, Guangzhou City, Guangdong Province, 510515, People’s Republic of China
& Guo-Kai Feng2 State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, 510060, People’s Republic of ChinaCorrespondence[email protected] [email protected]
show all
Pages 645-656
|
Published online: 24 Jun 2021
Reprints and Permissions
Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.
To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.
For more information please visit our Permissions help page.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.